AB0162 Rank Expression is Reduced in Circulating Monocytes from Ankylosing Spondylitis Patients. (10th June 2014)
- Record Type:
- Journal Article
- Title:
- AB0162 Rank Expression is Reduced in Circulating Monocytes from Ankylosing Spondylitis Patients. (10th June 2014)
- Main Title:
- AB0162 Rank Expression is Reduced in Circulating Monocytes from Ankylosing Spondylitis Patients
- Authors:
- Perpétuo, I.P.
Caetano-Lopes, J.
Vieira-Sousa, E.
Campanilho-Marques, R.
Ponte, C.
Canhão, H.
Ainola, M.
Fonseca, J.E. - Abstract:
- Abstract : Background: Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are systemic, immune-mediated diseases. RA's main targets are the peripheral joints while AS has the axial skeleton and enthesis as the principal affected areas. RA is characterized by bone erosions and impaired repair whilst AS is typified by bone overgrowth. The causes for these differences are not yet understood; however we hypothesize that AS patients' monocytes receive reduced osteoclastogenic stimuli and/or have abnormal capacity to respond to them. Objectives: The aim of this study was to characterize AS patients' bone remodeling and pro osteoclastogenesis inflammatory environment and monocyte phenotypes as compared to RA patients and healthy controls. Methods: Untreated AS or RA patients with active disease and age and gender-matched healthy donors were recruited for this study. Blood was collected for flow cytometry measurements of RANKL expression and monocyte subpopulation characterization. Serum was collected for cytokine and bone remodeling factors quantification. This study was approved by the hospital's ethics committee. Results: We found that RANKL T and B lymphocyte expression was significantly higher in AS and RA patients when compared to healthy donors (p=0.0445 and 0.0016, respectively). Frequency of both classical (CD14brightCD16negative) and non-classical (CD14dimCD16positive) was increased in AS and RA patients when compared to healthy donors (p<0.0001 and p=0.0227,Abstract : Background: Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are systemic, immune-mediated diseases. RA's main targets are the peripheral joints while AS has the axial skeleton and enthesis as the principal affected areas. RA is characterized by bone erosions and impaired repair whilst AS is typified by bone overgrowth. The causes for these differences are not yet understood; however we hypothesize that AS patients' monocytes receive reduced osteoclastogenic stimuli and/or have abnormal capacity to respond to them. Objectives: The aim of this study was to characterize AS patients' bone remodeling and pro osteoclastogenesis inflammatory environment and monocyte phenotypes as compared to RA patients and healthy controls. Methods: Untreated AS or RA patients with active disease and age and gender-matched healthy donors were recruited for this study. Blood was collected for flow cytometry measurements of RANKL expression and monocyte subpopulation characterization. Serum was collected for cytokine and bone remodeling factors quantification. This study was approved by the hospital's ethics committee. Results: We found that RANKL T and B lymphocyte expression was significantly higher in AS and RA patients when compared to healthy donors (p=0.0445 and 0.0016, respectively). Frequency of both classical (CD14brightCD16negative) and non-classical (CD14dimCD16positive) was increased in AS and RA patients when compared to healthy donors (p<0.0001 and p=0.0227, respectively). However, in the classical subpopulation RANK expression was lower in AS patients as compared to RA patients and healthy controls (p=0.0073). In accordance, CTX-I and P1NP serum level were also lower in AS patients than in healthy controls (p=0.0100 and p=0.0195, respectively). Conclusions: Despite comparable osteoclastogenic stimuli in AS and RA patients, RANK expression is reduced in AS circulating monocytes which may contribute to the bone forming phenotype observed in AS patients. Disclosure of Interest: None declared DOI: 10.1136/annrheumdis-2014-eular.5730 … (more)
- Is Part Of:
- Annals of the rheumatic diseases. Volume 73:Supplement 2(2014)
- Journal:
- Annals of the rheumatic diseases
- Issue:
- Volume 73:Supplement 2(2014)
- Issue Display:
- Volume 73, Issue 2 (2014)
- Year:
- 2014
- Volume:
- 73
- Issue:
- 2
- Issue Sort Value:
- 2014-0073-0002-0000
- Page Start:
- 856
- Page End:
- 856
- Publication Date:
- 2014-06-10
- Subjects:
- Rheumatism -- Periodicals
616.723005 - Journal URLs:
- http://ard.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive ↗
http://www.bmj.com/archive ↗
http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N ↗ - DOI:
- 10.1136/annrheumdis-2014-eular.5730 ↗
- Languages:
- English
- ISSNs:
- 0003-4967
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18365.xml